Minnesota Oncology Hematology, P.A.

Clinical research site in Fridley, Minnesota · 480 OSBORNE RD NE, SUITE 220, FRIDLEY, MN 55432 · (763) 786-1620

Part of Minnesota Oncology Hematology

As of July 2026, 2 paid clinical trials are recruiting at Minnesota Oncology Hematology, P.A. in Fridley, Minnesota. Active studies at this site focus on Melanoma alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Minnesota Oncology Hematology, P.A. (2)

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

for Melanoma

93 locations incl. Chandler

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18+

Code: NCT06246916·Phase 3·Recruiting·Listed Feb 2024

Apply to this trial

A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

for Colorectal Neoplasms

104 locations incl. Glendale

Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All·Age: 18+

Code: NCT05253651·Phase 3·Recruiting·Listed Feb 2022

Apply to this trial

More research sites in Fridley

Unity Hospital (4 trials)
Minnesota Oncology Hematology, P.A (1 trial)
Minnesota Oncology Hematology, PA (1 trial)
Virginia Piper Cancer Institute Mercy Hospital-Unity Campus (1 trial)

Explore more

Paid clinical trials in Fridley, MN · Minnesota clinical trials